Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

New Alzheimer’s drug, lecanemab slows disease but divides opinions

November 30, 2022 Research and Development

Japanese drugmaker Eisai and its US partner Biogen have announced that their new drug to treat Alzheimer’s disease appeared to …
News

RadNet’s Aidence AI subsidiary and Google Health enter into agreement to bring lung cancer screening model to market

November 30, 2022 Research and Development

Aidence, an AI subsidiary of RadNet which looks at lung health, has partnered with Google Health to license Google Health’s …
News

University of Texas and Novartis Pharmaceuticals develop new computer platform for easier drug discovery

November 29, 2022 Research and Development

Researchers from both the University of Texas, US and Novartis Pharmaceuticals have developed a computer-based platform which appears to make …
News

Two-dose chemotherapy drug enters clinical trial for cancer patients

November 28, 2022 Research and Development

South Korean biotech firm Hyundai Bioscience’s innovative chemotherapy drug may be able to complete cancer treatments in two doses. The …
News

Lunit first SaMD in APAC region to secure CE mark and UKCA certification for AI-based radiology solution

November 23, 2022 Research and Development

Lunit, a South Korean medical software company, has become the first software as a medical device (SaMD) company in the …
News

BioInnovation Institute reveals new cohort entering Venture Lab programme

September 7, 2022 Research and Development

 The group consists of nine ventures plus two corporate-sponsored innovation projects from Novo Nordisk – all aligned with BII’s focus …
News

New study reveals the range of co-morbidities faced by patients with type 2 diabetes

August 24, 2022 Research and Development

A new study has revealed the range and type of illnesses that people with type 2 diabetes are living with, …
News

Oxford Uni scientists study Siga’s Tpoxx for protection against monkeypox

August 24, 2022 Research and Development

The team at Oxford University, who conducted the landmark RECOVERY trial of COVID-19 therapies, is now studying if Siga Technologies’ …
News

Paediatric Investigation Plan approved by MHRA

August 24, 2022 Research and Development

Northwest Biotherapeutics has announced the approval from the MHRA of the company’s Paediatric Investigation Plan (PIP). The development, regulatory review, …
News

Togo becomes first country to eliminate four neglected tropical diseases

August 24, 2022 Research and Development

WHO has announced that the Republic of Togo has been confirmed as the first country to eliminate four devastating neglected …
News
dna-g009a668c7_1280

Evonetix commences access programme for synthesised DNA

August 17, 2022 Research and Development

Researchers are invited to apply to receive DNA that has been synthesised using Evonetix’s platform Evonetix has announced the opening …
News

Lynparza combination therapy gets FDA priority review for prostate cancer

August 17, 2022 Research and Development

Lynparza is being jointly developed by UK-based AstraZeneca and MSD AstraZeneca’s supplemental new drug application for Lynparza (olaparib) in combination …
News
surgery-1822458_960_720

Successful study to change the blood type of donor kidneys means access for more BAME recipients

August 17, 2022 Research and Development

Scientists at the University of Cambridge have successfully altered the blood type of donor kidneys in a study which could …
News
istockphoto-1266494637-170667a

Patient with HNSCC dosed with triple combination therapy in Phase II of Genexine clinical trial

August 17, 2022 Research and Development

Genexine, a South Korean clinical-staged biopharmaceutical company, have announced the dosing with triple combination therapy of the first patient with …
News
x-ray-6841384__480

Study highlights major factors in shaping cross-disorder cortical abnormalities

August 10, 2022 Research and Development

The study began by constructing maps of cortical abnormalities from thirteen neurodevelopmental, neurological, and psychiatric disorders. These maps came from …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026